Form 144 - Report of proposed sale of securities:
SEC Accession No. 0001437749-24-036485
Filing Date
2024-12-02
Accepted
2024-12-02 17:14:25
Documents
1

Document Format Files

Seq Description Document Type Size
1 primary_doc.html 144  
1 primary_doc.xml 144 3033
  Complete submission text file 0001437749-24-036485.txt   4614
Mailing Address 6801 N CAPITAL OF TEXAS HIGHWAY BUILDING 1; SUITE 300 AUSTIN TX 78731
Business Address 6801 N CAPITAL OF TEXAS HIGHWAY BUILDING 1; SUITE 300 AUSTIN TX 78731 512-501-2444
CASSAVA SCIENCES INC (Subject) CIK: 0001069530 (see all company filings)

IRS No.: 911911336 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 144 | Act: 33 | File No.: 001-41905 | Film No.: 241520092
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 7801 N. CAPITAL OF TX HWY SUITE 260 AUSTIN TX 78731
Business Address
Schoen Eric (Reporting) CIK: 0001532303 (see all company filings)

Type: 144